Literature DB >> 9442377

NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells.

S Wissink1, A van de Stolpe, E Caldenhoven, L Koenderman, P T van der Saag.   

Abstract

A kappa B-site was identified in the promoter of the intercellular adhesion molecule-1 (ICAM-1) gene, which is involved in regulation of ICAM-1 expression by tumor necrosis factor alpha (TNF-alpha) and glucocorticoids. We now report on the transcription factors which bind and transactivate this enhancer sequence. In vitro, the ICAM-1 kappa B site appeared to bind RelA and c-Rel homodimers as well as heterodimers with NF-kappa B1, but weakly NF-kappa B1 homodimers. In addition, both RelA and c-Rel, but not NF-kappa B1, were shown to transactivate an ICAM-1 kappa B-reporter construct. In monocytic THP-1 cells TNF-alpha induced two nuclear complexes which in vitro bound to the ICAM-1 kappa B site. Using antibodies in an electrophoretic mobility supershift assay, one of these complexes was shown to contain NF-kappa B1 and RelA, and to bind with higher affinity to the consensus kappa B site in the HIV long terminal repeat. The second complex contained RelA, and exhibited higher affinity towards the ICAM-1 kappa B than to the HIV kappa B site. The glucocorticoid receptor was shown to repress activity of both the RelA homodimer and the NF-kappa B1/RelA heterodimer. We argue that in vivo RelA homodimers are likely to play a dominant role in TNF-alpha-induced ICAM-1 transcription in monocytic cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9442377     DOI: 10.1016/s0171-2985(97)80026-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

Review 1.  The NF-kappaB family of transcription factors and its regulation.

Authors:  Andrea Oeckinghaus; Sankar Ghosh
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

2.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

3.  NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.

Authors:  Mei Xu; Rachel A Katzenellenbogen; Carla Grandori; Denise A Galloway
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

4.  Identification of proteins within the nuclear factor-kappa B transcriptional complex including estrogen receptor-alpha.

Authors:  Irv Feldman; Gerald M Feldman; Charlotte Mobarak; Jeffrey C Dunkelberg; Kimberly K Leslie
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

5.  RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.

Authors:  H Y Jiang; Constantinos Petrovas; Gail E Sonenshein
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Paeoniflorin suppresses the expression of intercellular adhesion molecule-1 (ICAM-1) in endotoxin-treated human monocytic cells.

Authors:  Lei Jin; Li-Min Zhang; Ke-Qiang Xie; Yang Ye; Linyin Feng
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  Global analysis of glycoproteins identifies markers of endotoxin tolerant monocytes and GPR84 as a modulator of TNFα expression.

Authors:  Mario M Müller; Roland Lehmann; Tilman E Klassert; Stella Reifenstein; Theresia Conrad; Christoph Moore; Anna Kuhn; Andrea Behnert; Reinhard Guthke; Dominik Driesch; Hortense Slevogt
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

8.  Toxoplasma effector-induced ICAM-1 expression by infected dendritic cells potentiates transmigration across polarised endothelium.

Authors:  Emily C Ross; Arne L Ten Hoeve; Jeroen P J Saeij; Antonio Barragan
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

Review 9.  Safety of intranasal corticosteroids in acute rhinosinusitis.

Authors:  Pascal Demoly
Journal:  Am J Otolaryngol       Date:  2008-06-16       Impact factor: 1.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.